Search results
May 31, 2023 · It is expected that by the end of 2026, almost 1 billion people will be protected against yellow fever through vaccination. References. Garske T. et al. Yellow fever in Africa: Estimating the burden of disease and impact of mass vaccination from outbreak and serological data. PLoS Med. 2014;11(5):e1001638 - https://pubmed.ncbi.nlm.nih.gov/24800812/
May 24, 2014 · Lifetime validity of one dose of Yellow fever vaccine. Amendment to Annex 7 of IHR (2005) 24 May 2014
Mar 2, 2017 · In countries where yellow fever occurs, WHO strongly recommends routine vaccination for everyone older than 9 months. During an epidemic, when a mass vaccination campaign is underway, the vaccine is given to everyone over the age of 6 months (when the risk of disease is higher than an adverse event from the vaccine).
Aug 2, 2023 · Vaccination is the most important measure for preventing yellow fever. Yellow fever vaccine is safe, affordable, and a single dose provides life-long protection against yellow fever disease. The yellow fever vaccine provides immunity within one week in 95% of people vaccinated. A booster dose is not needed. Yellow fever vaccination is carried ...
Nov 18, 2022 · Overview . The Country List is a compilation of key information to facilitate international travel. The information provided for each country includes vaccination requirements for international travellers as provided by States Parties to the International Health Regulations (2005) (IHR), as well as WHO recommendations for vaccination against yellow fever, poliomielytis, and malaria prophylaxis.
Nov 8, 2023 · Vaccination is the single most important measure for preventing yellow fever. The prevention of outbreaks can only be achieved if the majority of the population is immunized. The yellow fever vaccine is safe and affordable, and a single dose provides life-long immunity against the disease.
Jul 5, 2013 · This updated position paper on yellow fever (YF) vaccines and vaccination replaces the previous 2003 WHO position paper and summarizes recent developments in the field. Recommendations on the use of YF vaccines were last discussed by SAGE at its meeting in April 2013.
Term of protection provided by vaccination against yellow fever infection, and validity of related IHR certificate of vaccination, extended to life of the person vaccinated Yellow fever is the only disease specified in the International Health Regulations (2005) (IHR (2005)) for which countries may require proof of vaccination from travellers as a
At its June 2008 session, GACVS recommended that in light of the significant number of doses of yellow fever vaccine being delivered (and planned to be delivered) in preventive vaccination campaigns in endemic countries, some of which have a significant prevalence of HIV infection, appropriate follow-up studies after vaccine use should be conducted to improve the data on the safety and immunogenicity of this vaccine in individuals infected with HIV. 7 GACVS has reviewed the latest data from ...
Apr 26, 2016 · Yellow fever, which is spread by infected mosquitoes, particularly the Aedes mosquito, is an acute viral haemorrhagic disease for which there is currently no specific treatment. A small proportion of patients who contract the virus develop severe symptoms and approximately half of those die within 10 to 14 days.
